NovaBridge Biosciences Statistics

Total Valuation

FRA:0VY has a market cap or net worth of EUR 366.73 million. The enterprise value is 173.30 million.

Market Cap	366.73M
Enterprise Value	173.30M

Important Dates

The next estimated earnings date is Wednesday, April 1, 2026.

Earnings Date	Apr 1, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+6.88%
Shares Change (QoQ)	+27.55%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	59.97M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	1.66
P/TBV Ratio	1.66
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-7.72
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-11.96

Financial Position

The company has a current ratio of 14.47, with a Debt / Equity ratio of 0.01.

Current Ratio	14.47
Quick Ratio	14.24
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	-0.19
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-13.29%
Revenue Per Employee	n/a
Profits Per Employee	-701,177
Employee Count	32
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +238.30% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+238.30%
50-Day Moving Average	3.54
200-Day Moving Average	2.60
Relative Strength Index (RSI)	45.24
Average Volume (20 Days)	5

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	4.57

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-29.61M
Pretax Income	-22.44M
Net Income	-22.44M
EBITDA	-29.54M
EBIT	-29.61M
Earnings Per Share (EPS)	-0.26

Full Income Statement

Balance Sheet

The company has 194.56 million in cash and 2.79 million in debt, with a net cash position of 191.77 million.

Cash & Cash Equivalents	194.56M
Total Debt	2.79M
Net Cash	191.77M
Net Cash Per Share	n/a
Equity (Book Value)	220.67M
Book Value Per Share	1.91
Working Capital	184.68M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -14.45 million and capital expenditures -38,354, giving a free cash flow of -14.48 million.

Operating Cash Flow	-14.45M
Capital Expenditures	-38,354
Free Cash Flow	-14.48M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

FRA:0VY does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.88%
Shareholder Yield	-6.88%
Earnings Yield	-6.12%
FCF Yield	-3.95%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1